Enlaza Therapeutics

Website
Current Valuation
$295.0M
As of September 10, 2025
Total Funding Raised
$176.0M
Last Round
Later Stage VC

$15.0M

Last Funding
Sep 2025

Funding date

Capital Efficiency
1.68x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

Enlaza Therapeutics is currently valued at $295.0M as of September 10, 2025. The company has raised a total of $176.0M in funding.

Capital Efficiency

With a capital efficiency ratio of 1.68x, Enlaza Therapeutics has achieved a valuation that is 1.68 times the total capital raised.

Track Enlaza Therapeutics Valuation Updates

Get notified when Enlaza Therapeutics raises new funding or valuation changes

Explore More Data
Detailed analysis for Enlaza Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Enlaza Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Enlaza Therapeutics Worth in 2026?

Enlaza Therapeutics is a leading private company in the technology sector. Track Enlaza Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Enlaza Therapeutics Valuation is Determined

Private company valuations like Enlaza Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.